← Open Payments lookup

OLIVIA HOCKENJOS: Open Payments

NPI 1174120307 · HAUGHTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,493 in 72 payments from 11 companies in 2025. Trend: 2023 $37 · 2024 $910 · 2025 $1,493

Food & beverage: $1,416Education: $77
CompanyPaymentsAmount
Janssen Biotech, Inc.17$445
Ardelyx, Inc.14$263
Takeda Pharmaceuticals U.S.A., Inc.9$183
ABBVIE INC.17$180
Regeneron Healthcare Solutions, Inc.1$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$102
Madrigal Pharmaceuticals1$67
Gilead Sciences, Inc.3$61
Mallinckrodt Hospital Products Inc.2$36
Ipsen Biopharmaceuticals, Inc1$16

Products named: TREMFYA, IBSRELA, ENTYVIO, XIFAXAN, SKYRIZI, RINVOQ, REZDIFFRA, TERLIVAZ.

Industry payments across LA — which companies pay providers there.